SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: F. Jay Abella, III who wrote (3387)4/16/1998 9:04:00 PM
From: Dauntless  Respond to of 7041
 
Jay, a pathetic post

Give us a break - you are so desperate to cast some negativity on Zonagen that you would say anything.

<<<Not saying that this will happen with ZONA>>>

Well then it's simple - don't say it. The company has a ton of cash in the bank, another milestone payment will probably come their way when the NDA is filed. Maybe another when the FDA accepts the submission (30 days after filing). IMHO, yours was a BS post.



To: F. Jay Abella, III who wrote (3387)4/16/1998 9:43:00 PM
From: Hank  Respond to of 7041
 
The head trader at a major brokerage firm once told me that he considers buy recs to be the sign of an impending top. Downgrades are the sign of an impending bottom. Like you said, this often happens a couple of months after the fact. Maybe somebody is not so confident of how ZONA's presentation will be received at the June conference.



To: F. Jay Abella, III who wrote (3387)4/16/1998 10:03:00 PM
From: Anaxagoras  Read Replies (1) | Respond to of 7041
 
Look, first, Oppie isn't some bucket shop (that isn't to say, however, that their recs are never self-serving).

Second, you're vaguely suggesting that ZONA intends to do some selling of shares and Oppie is trying to position themselves for the investment banking:
<<Many times, in biotech especially, the "recommendations" are often followed by stock to sell (i.e., an S-3 filing).>>

With all the cash on hand, who do you think is gonna be selling so that the company will have to file an S-3 in the next year or so? Come on, use your imagination, tell me a story....

Anaxagoras